本研究旨在探讨AML1/ETO融合基因阳性的急性髓系白血病M2(acute myeloid leukemia with maturation,AML/M2)患者FLT3基因表达量与临床症状和预后的相关性及其意义。采用RQ-PCR法定量检测21例AML1/ETO阳性AML-M2患者初诊骨髓标本中FLT3...
supported by grants from the National Natural Science Foundation of China(90919044 and 81170518);High and New Technology Pro-gram of PLA(2010gxjs091);Capital Medical Development Scientific Research Fund(No.2007-2040)